When Romance and Allergies Don't Mix
SUNDAY, Nov. 14 (HealthDay News) -- The course of true love may
not run smoothly for some people with highly sensitive allergies,
experts say, since kissing or other intimate contact can pose risks
for sometimes serious reactions.
Among Cell-Phone Junkies, Rash on the Rise
SUNDAY, Nov. 14 (HealthDay News) -- If you're an incessant cell
phone user and a mysterious rash appears along your jaw, cheek or
ear, chances are you're allergic to nickel, a metal commonly used
in cell phones.
Video Games Not Harmful to Most Teens: Study
MONDAY, Nov. 15 (HealthDay News) -- Most teens who play video
games don't fall into unhealthy behaviors, but an "addicted"
minority may be more likely to smoke, use drugs, fight or become
depressed, a new Yale University study suggests.
CPR Guidelines May Lower Out-of-Hospital Death Rate
SATURDAY, Nov. 13 (HealthDay News) -- When implemented, the
American Heart Association's 2005 guidelines on cardiopulmonary
resuscitation (CPR) can dramatically boost survival rates among
people being treated outside a hospital setting, according to an
Study Urges Teens to Cut Down on Salt
SUNDAY, Nov. 14 (HealthDay News) -- Teens who eat less salt
lower their long-term risk for high blood pressure, heart disease
and stroke, new research indicates.
Death of Loved One May Trigger Elevated Heart Rate
SUNDAY, Nov. 14 (HealthDay News) -- In the months following the
death of a spouse or a child, the surviving spouse or parent may
face a higher risk of heart attack or sudden cardiac death due to
an increased heart rate, new research suggests.
Pacemakers May Help Predict Strokes
MONDAY, Nov. 15 (HealthDay News) -- Doctors may be able to
monitor stroke risk in pacemaker recipients by tracking the
incidence of a type of irregular heartbeat called atrial
fibrillation, new research suggests.
School Programs for Cardiac Arrest Saving Lives
MONDAY, Nov. 15 (HealthDay News) --School-based programs that
teach CPR and the proper use of automated external defibrillators
(AED) boost survival rates from sudden cardiac arrest, new research
Device Improves Survival of Heart Failure Patients: Study
SUNDAY, Nov. 14 (HealthDay News) -- Canadian researchers report
that an implantable device called a resynchronization
therapy-defibrillator helps keep the left side of the heart pumping
properly, extending the life of heart failure patients.
Early 'Pot' Use May Harm Brain More: Study
MONDAY, Nov. 15 (HealthDay News) -- People who started smoking
marijuana at a young age did much worse on tests of executive brain
function than those who started smoking when they were older, a new
Antibody Linked to Allergies on the Rise
SATURDAY, Nov. 13 (HealthDay News) -- It's a common belief that
as you get older, your allergy symptoms will wane, but a new study
suggests it's possible that even more older people will be
experiencing allergies than ever before.
Minneapolis Study Points to Sharp Drop in Smoking Rates
SUNDAY, Nov. 14 (HealthDay News) -- The Twin Cities of
Minneapolis and St. Paul saw a sharp decline in the number of adult
smokers over the last three decades, perhaps mirroring trends
elsewhere in the United States, experts say.
A Little Alcohol May Help the Heart: Studies
SUNDAY, Nov. 14 (HealthDay News) -- Moderate drinking may be
good for your health -- better, in fact, than not drinking at all,
according to a trio of studies presented Sunday at the American
Heart Association annual meeting in Chicago.
External Defibrillators Not Much Help in Hospitals
MONDAY, Nov. 15 (HealthDay News) -- Although automated external
defibrillators have been found to reduce heart attack death rates
in public places such as restaurants, malls and airplanes, they
have no benefit and, paradoxically, seem to increase the risk of
death when used in hospitals, a new study suggests.
New Blood Thinner a Promising Alternative to Warfarin
MONDAY, Nov. 15 (HealthDay News) -- A new blood thinner might be
a viable alternative to warfarin (Coumadin), the standard for
decades to treat patients with the dangerous heart rhythm disorder
known as atrial fibrillation.
Vyvanse Approved for Adolescent ADHD
MONDAY, Nov. 15 (HealthDay News) -- Vyvanse (lisdexamfetamine
dimesylate) capsules have been approved by the U.S. Food and Drug
Administration to treat attention deficit hyperactivity disorder
(ADHD) among adolescents aged 13 to 17, maker Shire Pharmaceuticals
Halaven Approved for Late-Stage Breast Cancer
MONDAY, Nov. 15 (HealthDay News) -- Halaven (eribulin mesylate)
has been approved by the U.S. Food and Drug Administration to treat
metastatic (spreading) breast cancer among people who have had at
least two prior chemotherapy treatments for late-stage disease.